Rotta Sounds Off On FDA Rejection Of Glucosamine Claim
This article was originally published in The Tan Sheet
Executive Summary
Rotta Pharmaceuticals says FDA made "errors" in its decision to reject a qualified health claim for glucosamine and osteoarthritis